retatrutide phase 2 nejm 2023 obesity trial jastreboff Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide: The Three Receptors It

If you want the deeper science on how the two work together, see our primer on prebiotics, probiotics, and synbiotics

This is where the marketing often gets ahead of the medicine

Libido is a brain-driven process powered by dopamine signaling

Generic Semaglutide at In-Person Canadian Pharmacies Cash retail prices for generic semaglutide at Canadian pharmacies are now coming in below the telehealth alternatives, based on early Canadian consumer reports

Jedn z najwikszych barier w dostpie do nowoczesnego leczenia otyoci w Polsce jest brak refundacji przez Narodowy Fundusz Zdrowia (NFZ)

Aging rewires metabolism, immunity, and gene regulation across organs, steadily sapping strength, cognition, and resilience